In the realm of pharmaceutical synthesis, specific chemical compounds act as linchpins, enabling the creation of life-saving medications. CAS 697739-03-0, chemically known as Methyl 5-fluoro-2-methyl-3-nitrobenzoate, is one such compound, playing a critical role in the development of Rucaparib. As a prominent manufacturer and supplier of this key intermediate, we aim to provide clarity on its significance and how to procure it reliably.

Methyl 5-fluoro-2-methyl-3-nitrobenzoate is recognized for its indispensable function in the synthetic pathway leading to Rucaparib, a targeted therapy for various cancers. The demand for this compound is driven by the increasing clinical application and research surrounding Rucaparib. For any pharmaceutical company, ensuring the purity and consistency of CAS 697739-03-0 is non-negotiable, as it directly influences the quality of the final active pharmaceutical ingredient (API). Our rigorous quality control measures, including HPLC analysis confirming ≥98.0% purity, underscore our commitment as a leading manufacturer.

As a global supplier, we understand the challenges procurement managers face in sourcing critical raw materials. Our operations in China are geared towards providing a stable and competitive supply of Methyl 5-fluoro-2-methyl-3-nitrobenzoate. We offer this vital intermediate in standard 25 kg drums, ensuring ease of handling and storage for our clients worldwide. Investigating the price and availability from a reputable manufacturer is the first step towards securing your production needs.

For research scientists and formulators, access to high-quality chemical building blocks is essential for innovation. We position ourselves not just as a supplier, but as a partner in your drug development journey. Whether you are looking to buy in bulk or require specific technical information about CAS 697739-03-0, our experienced team is equipped to assist. Explore the advantages of working with a dedicated manufacturer that prioritizes quality, reliability, and customer satisfaction for your pharmaceutical intermediate needs.